JACOBSON, Ira, Patrick MARCELLIN, Jenny HETHCOTE, Philippe MATHURIN, Ed. J. GANE, Peter BUGGISCH, Petr HUSA, Zachary KRASTEV, Jeff SORBEL, Jane ANDERSON, Elsa MONDOU and Franck ROUSSEAU. Safety and tolarability of 96 weeks of tenofovir disoproxil fumarate (TDF) treatment in HBeAg negative and positive patients infected with chronic hepatitis B (CHB). Gastroenterology. 2009, vol. 136, 5 Suppl. 1, p. W1814, 1 pp. ISSN 1211-9059.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Safety and tolarability of 96 weeks of tenofovir disoproxil fumarate (TDF) treatment in HBeAg negative and positive patients infected with chronic hepatitis B (CHB)
Name in Czech Bezpečnost a tolerance 96 týdnů léčby tenofovirem u HBeAg negativních positivních pacientů s chronickou hepatitidou B.
Authors JACOBSON, Ira, Patrick MARCELLIN, Jenny HETHCOTE, Philippe MATHURIN, Ed. J. GANE, Peter BUGGISCH, Petr HUSA, Zachary KRASTEV, Jeff SORBEL, Jane ANDERSON, Elsa MONDOU and Franck ROUSSEAU.
Edition Gastroenterology, 2009, 1211-9059.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30300 3.3 Health sciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Petr Husa, CSc., učo 945. Changed: 21/7/2009 12:57.
PrintDisplayed: 5/9/2024 02:38